Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases
Launched by UNIVERSITY MARIBOR · Jan 17, 2024
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
The investigators reviewed the existing literature and found little research on the use of Continuous Glucose Monitoring (CGM) and visualization of SCORE2 prognostic model in healthy populations and how they can influence lifestyle change. The investigators will conduct a randomised control trial with 3 intervention groups and 1 control gropu. The investigators also found that primary care nurses are still using paper-based methods to calculate CVDs by using colour-coded charts. Therefore, the investigators will use the visual tool of the SCORE2 scale to identify possible increased particip...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • individuals ages more than 40 years
- • without serious disease progression
- • at least one risk factor for CVDs
- Exclusion Criteria:
- • individuals younger than 40 years
- • with serious disease progression
- • without risk factor for CVDs
About University Maribor
University Maribor, a leading research institution in Slovenia, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its robust academic framework and state-of-the-art facilities to conduct high-quality research that addresses pressing medical challenges. By fostering partnerships with industry stakeholders and healthcare providers, University Maribor aims to translate scientific discoveries into practical therapies, ultimately enhancing patient outcomes and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maribor, , Slovenia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported